ASCPRO consists of symptom researchers, government and funding agency representatives, pharmaceutical company representatives, patient advocates, and policy makers in cancer care quality control. Its deliberations will be augmented by invited specialists and targeted meetings for specific symptoms (such as fatigue, sleep disturbance, cognitive dysfunction) or trial design and analysis issues.

At present, membership is restricted to invited participants of specific task force groups.

 

Organizational Structure

ASCPRO’s organizational structure includes the members and several subsets of the whole, including an Executive Committee, targeted Task Forces, and Expert Advisors. The membership roster includes several of the attendees of an initial meeting in Charlottesville, Virginia in August 2006, along with other stakeholders. The Executive Committee consists of the two co-chairs and one or more additional members who represent academia and/or industry. The Expert Advisors comprise experts from academia and industry who are knowledgeable in symptom measurement, trial design, and statistics. ASCPRO members will chair specific Task Forces and will incorporate Expert Advisors when needed.

ASCPRO members represent skill sets, insights, and experience that are important for the organization's goals; however, they do not speak for their respective organizations or companies in ASCPRO discussions and publications.

 

Membership Roster

ASCPRO members set meeting schedules and develop group hypotheses to take to pharmaceutical manufacturers for consideration for funding and data sharing. The members will select topics for study, create topic task force groups, and review task force products. Ultimately, the group will make recommendations about symptom assessment in clinical trials.

EXECUTIVE COMMITTEE CONTENT EXPERT MEMBERS INDUSTRY MEMBERS
Charles S. Cleeland, PhD, Co-Chair
The University of Texas M. D. Anderson Cancer Center

Jeff A. Sloan, PhD, Co-Chair
Mayo Clinic College of Medicine

Donald C. Manning, MD, PhD
Shionogi USA Inc

 

Andrea M. Barsevick, PhD, RN, AOCN
Fox Chase Cancer Center

Beth Barber
Amgen, Inc.

Ethan Basch, MD, MPH
Memorial Sloan-Kettering Cancer Center

Andrew Bottomley, PhD
European Organisation for Research and Treatment of Cancer

David Cella, PhD
Evanston Northwestern Healthcare

Stephen Joel Coons, PhD
Critical Path Institute

Amylou Dueck, PhD
Mayo Clinic

William Frey, PhD
Westat

Marlene H. Frost, RN, PhD, AOCN
Mayo Clinic Women's Cancer Program

Patricia (Patti) Ganz, MD
UCLA School of Public Health

Michele Y. Halyard, MD
Mayo Clinic

Nora A. Janjan, MD, MPSA
 

Mark P. Jensen, PhD
University of Washington

Valen E. Johnson, PhD
The University of Texas M. D. Anderson Cancer Center

Ronald M. Lazar, PhD
Columbia University Medical Center

Tito R. Mendoza, PhD
The University of Texas M. D. Anderson Cancer Center

Francesca Martinelli
European Organisation for Research and Treatment of Cancer (EORTC)

Christina A. Meyers, PhD
The University of Texas M. D. Anderson Cancer Center

Chantal Quinten
European Organisation for Research and Treatment of Cancer (EORTC)

Jane A. Scott, PhD
MAPI Values, LTD

Qiuling Shi, MD, PhD
The University of Texas MD Anderson Cancer Center

Michael Sharpe, MD
University of Edinburgh

Thomas J. Smith, MD
Virginia Commonwealth University

Dennis C. Turk, PhD
University of Washington

Ralph R. Turner, DrPH
Phase V Technologies, Inc.

Xin Shelley Wang, MD, MPH
The University of Texas MD Anderson Cancer Center

Jeffrey S. Wefel, PhD
The University of Texas MD Anderson Cancer Center

Loretta A. Williams, PhD, RN
The University of Texas MD Anderson Cancer Center

Mohan Bala, PhD
sanofi aventis

Vamsi Bollu
Novartis

Connie Chen, PharmD
Pfizer, Inc.

Anthony A. Golsorkhi, MD
Cephalon, Inc.

Kelly Grotzinger, PhD, MBA
GlaxoSmithKline

Astra M. Liepa, PharmD
Eli Lilly and Company

Zhimei (Jamae) Liu, PhD
 

Rajiv Mallick, PhD
Daiichi-Sankyo, Inc.

Jay Pearson, PhD
Merck & Co., Inc.

Bhash Parasuraman
AstraZeneca

Edwin Rock, MD, PhD
Otsuka Pharmaceutical Development and Commercialization, Inc.

Greg Rossi, PhD
Genentech, Inc.

Joseph W. Stauffer, DO
Alpharma

Leslie A. Tive, PhD
Pfizer, Inc.

Yasuhiro Torigoe, PhD
Genentech

Sarah Donaldson Trease
Genentech

Ingela K. Wiklund, PhD
GlaxoSmithKline

 

NON-MEMBER EXPERT ADVISORS

Dianne Reeves
National Cancer Institute